| [Ala1,3,11,15]-Endothelin (53-63) |
|
|
|
| [Ala1,3,11,15]-Endothelin (53-63) TFA |
|
|
98.18% |
| [Ala18] Endothelin-1, human |
|
|
|
| [Ala2] Endothelin-3, human |
|
|
|
| [Asn18] Endothelin-1 (swine, human) |
|
|
|
| [Lys4] Sarafotoxin S6c |
|
|
|
| A-127722 |
|
|
|
| A-192621 |
|
|
99.92% |
| ABT-546 |
|
|
|
| ACT-373898 |
|
|
|
| Aminaftone |
|
|
|
| ANP (1-30), frog |
|
|
|
| AP 811 acetate |
|
|
|
| Aselacin A |
|
|
|
| AT1R antagonist 4 |
|
|
|
| Atrasentan sodium |
|
|
|
| Atrial natriuretic peptide (3-28) (human) |
|
|
99.86% |
| Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse |
|
|
99.55% |
| Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse TFA |
|
|
99.32% |
| ATZ-1993 |
|
|
|
| BE 24566B |
|
|
|
| Big Endothelin-1 (22-38), human |
|
|
|
| Big endothelin-1 (rat 1-39) |
|
|
|
| Big endothelin-3 (Human, 1-41 amide) |
|
|
|
| BMS 182874 |
|
|
99.85% |
| BMS 182874 hydrochloride |
|
|
|
| BMS-187308 |
|
|
|
| BMS-193884 |
|
|
|
| BMS-248360 |
|
|
|
| Bosentan-d4 |
|
|
|
| BQ-123 |
|
|
99.91% |
| BQ-123 TFA |
|
|
|
| BQ-3020 |
|
|
|
| BQ-3020 ammonium |
|
|
98.96% |
| BQ-610 |
|
|
|
| BQ-788 |
|
|
99.70% |
| BQ-788 sodium salt |
|
|
99.33% |
| C-Type Natriuretic Peptide (CNP) (1-22), human TFA |
|
|
99.07% |
| Carperitide |
|
|
|
| Carperitide acetate |
|
|
99.78% |
| Cgs 27830 |
|
|
|
| CH-141 |
|
|
|
| CI-1020 |
|
|
|
| Clazosentan |
|
|
99.50% |
| Clazosentan disodium |
|
|
99.94% |
| Daglutril |
|
|
|
| DEDN6526A |
|
|
|
| DEDN6526A Antibody |
|
|
|
| Diosuxentan |
|
|
|
| Edonentan |
|
|
99.13% |
| Endothelin (16-21) |
|
|
|
| Endothelin 1 (swine, human) TFA |
|
|
99.77% |
| Endothelin 1 (swine, human), Alexa Fluor 488-labeled |
|
|
|
| Endothelin-2 (49-69), human |
|
|
99.86% |
| Endothelin-2 (49-69), human TFA |
|
|
99.21% |
| Endothelin-3, human, mouse, rabbit, rat |
|
|
97.58% |
| Endothelin-3, human, mouse, rabbit, rat TFA |
|
|
99.57% |
| Enrasentan |
|
|
98.39% |
| ETA antagonist 1 |
|
|
|
| ETA antagonist 2 |
|
|
|
| Fandosentan potassium |
|
|
|
| FR139317 |
|
|
|
| H-Trp-Phe-OH |
|
|
99.87% |
| HJP 272 |
|
|
|
| IRL 1038 |
|
|
|
| IRL 2500 |
|
|
99.27% |
| IRL-1620 |
|
|
99.61% |
| IRL-1620 TFA |
|
|
98.73% |
| IRL-3630 |
|
|
|
| J-104132 |
|
|
|
| JKC 302 |
|
|
|
| K-8794 |
|
|
|
| Kendomycin |
|
|
92.60% |
| L-749329 |
|
|
|
| Methylsolfonyl 25(S)-Δ7-dafachronic acid |
|
|
|
| Aprocitentan-d4 |
|
|
98.76% |
| Nebentan |
|
|
|
| Nebentan potassium |
|
|
98.30% |
| Nebentan potassium (Standard) |
|
|
|
| Patecibart |
|
|
97.77% |
| PD 142893 |
|
|
|
| PD 145065 |
|
|
|
| PD 155080 |
|
|
|
| PD 156252 |
|
|
|
| PD-156707 |
|
|
99.92% |
| PD-159020 |
|
|
|
| PD151242 |
|
|
|
| Piperitenone oxide |
|
|
|
| Rendomab B4 |
|
|
|
| RES-701-1 |
|
|
|
| RES-701-3 peptide TFA |
|
|
|
| Ro 46-2005 |
|
|
98.32% |
| Ro 46-8443 |
|
|
98.93% |
| S-1255 |
|
|
|
| Sarafotoxin S6a |
|
|
98.59% |
| Sarafotoxin S6a TFA |
|
|
|
| Sarafotoxin S6b |
|
|
|
| Sarafotoxin S6c |
|
|
98.19% |
| SB 247083 |
|
|
|
| SB-209670 |
|
|
|
| SB234551 |
|
|
|
| Sitaxsentan-13C6 |
|
|
|
| SM19712 |
|
|
99.0% |
| SM19712 free acid |
|
|
|
| Sparsentan |
|
|
99.87% |
| Sparsentan-d5 |
|
|
|
| Sulfatroxazole |
|
|
|
| TA-0201 |
|
|
|
| TAK 044 |
|
|
|
| TBC3711 |
|
|
|
| Tezosentan |
|
|
98.27% |
| WS009A |
|
|
|
| WS009B |
|
|
|
| Xipamide |
|
|
99.74% |
| ZD-1611 |
|
|
|
| Schisantherin D |
|
|
99.66% |
| Bosentan |
|
|
99.94% |
| Endothelin 1 (swine, human) |
|
|
98.90% |
| Sitaxsentan |
|
|
|
| Sitaxsentan sodium (Standard) |
|
|
98% |
| Sitaxsentan sodium |
|
|
98.83% |
| (Rac)-Ambrisentan-d3 |
|
|
|
| Ambrisentan |
|
|
99.95% |
| Ambrisentan sodium |
|
|
|
| Delphinidin 3-rutinoside chloride |
|
|
98.83% |
| Bosentan hydrate |
|
|
99.93% |
| Atrasentan hydrochloride |
|
|
99.82% |
| Sulfisoxazole |
|
|
99.90% |
| Sulfisoxazole diethanolamine |
|
|
|
| Sulfatroxazole-d4 |
|
|
|
| Edonentan hydrate |
|
|
|
| Darusentan |
|
|
98.60% |
| Avosentan |
|
|
98.15% |
| Aprocitentan |
|
|
99.55% |
| Atrasentan |
|
|
99.42% |
| Macitentan |
|
|
99.85% |
| Macitentan-d4 |
|
|
99.85% |
| Macitentan n-butyl analogue |
|
|
99.35% |
| Zibotentan |
|
|
99.37% |